Carrier screening, serum screening, NIPT, diagnostic testing, and hereditary cancer testing—all from one lab
It’s time for a more convenient and more comprehensive genetic testing experience for you and your patients.
At Integrated Genetics—a member of the LabCorp Specialty Testing Group—we offer continuity of care, from pre-pregnancy screens and pediatric diagnostics to cancer testing. Your patients can get all of the genetic tests they need from the same company.
Our support of you and your patients goes beyond testing services with genetic counseling services, financial assistance programs, and an online cost estimator to provide details about potential out-of-pocket costs.
With Inheritest, we offer choice for your patients—Comprehensive, Ashkenazi Jewish, Society (ACMG/ACOG) Guided, and Core (CF, SMA, fragile X syndrome) panels, as well as many single-gene testing options.
If a patient result is positive, we offer full gene sequencing for her reproductive partner, focusing exclusively on the gene of interest to deliver more relevant information.
For the first and second trimesters, Integrated Genetics offers choice through both serum screening and noninvasive prenatal testing—NIPT, sometimes called NIPS or cfDNA (cell-free DNA screening) options, including the only whole-genome NIPT currently available.
When your patient’s baby is identified as being at increased risk for certain disorders based on screening tests or abnormal ultrasound—or even if you or your patient simply want to start with as much accurate information as possible—we can help with a range of diagnostic tests, including prenatal, POC and pediatric or cord blood offerings. Where some genetic testing companies require patients to go elsewhere for diagnostic testing, we offer continuity.
Hereditary cancer testing
The continuity of care we offer you and your patients extends beyond reproductive testing into hereditary cancer testing as well.
Here, we also offer choice. BRCAssure focuses primarily on genetic indicators of ovarian and breast cancers, while VistaSeq offers 12 panel options that cover genetic mutations known to be associated with an increased risk of developing hereditary cancers (pancreatic, colorectal, endometrial, gastric, prostate cancers, and more).